<p>随着全球市场经历反弹，标普 500 指数和纳斯达克综合指数创下历史新高，小型股在温和通胀上升和经济指标混杂的复杂环境中航行。在这种动态环境中，识别有前景的小型公司需要关注那些具有强大基本面和潜在增长驱动因素的公司，以抵御更广泛市场的波动。</p>
<h3>全球十大未被发现的基本面强劲的宝藏股</h3>
<table>
<thead>
<tr>
<th>名称</th>
<th>债务股本比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>AIC</td>
<td>不适用</td>
<td>26.88%</td>
<td>54.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>CTCI 先进系统</td>
<td>39.96%</td>
<td>21.96%</td>
<td>24.04%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>先进国际多技术</td>
<td>35.32%</td>
<td>3.62%</td>
<td>1.11%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Saha-Union</td>
<td>0.84%</td>
<td>0.90%</td>
<td>15.45%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Alf Meem Yaa 医疗器械和设备</td>
<td>不适用</td>
<td>17.03%</td>
<td>18.37%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Nofoth 食品产品</td>
<td>不适用</td>
<td>15.75%</td>
<td>27.63%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>洪亮金融</td>
<td>0.07%</td>
<td>6.89%</td>
<td>6.61%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>新加坡投资与金融</td>
<td>0.29%</td>
<td>9.07%</td>
<td>12.24%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Mechema 化学国际</td>
<td>55.74%</td>
<td>-4.23%</td>
<td>-5.72%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>国家旅游与酒店公司</td>
<td>19.25%</td>
<td>0.67%</td>
<td>4.89%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们全球未被发现的基本面强劲的宝藏股筛选器中的 3161 只股票的完整列表。</p>
<p>在这里，我们重点介绍我们独家的筛选器中的几只最爱。</p>
<h2>山东百龙创园生物科技（SHSE:605016）</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 山东百龙创园生物科技有限公司在生物技术领域运营，市值为 88 亿人民币。</p>
<p><strong>运营：</strong> 该公司主要通过其生物技术业务产生收入。其市值约为 88 亿人民币，显示出其在该领域的重要地位。</p>
<p>山东百龙创园生物科技作为生物技术领域的灵活参与者，过去一年显示出 35.3% 的可观盈利增长，超越了面临下滑的行业同行。该公司的交易价格低于其估计的公允价值 7.1%，暗示潜在的低估。公司现金多于总债务，且债务股本比在五年内从 9% 降至 8.5%，财务健康状况似乎稳健。最近的季度业绩显示强劲表现，销售额从 2.52 亿人民币攀升至 3.13 亿人民币，净收入从 5400 万人民币上升至 8100 万人民币，同比增加。</p>
<ul>
<li>在我们的健康报告中更详细地了解山东百龙创园生物科技的潜力。</li>
<li>通过我们的历史报告深入了解山东百龙创园生物科技的过去趋势和表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c11836c5-6786-40b5-a4cc-a935a1cc2ed1/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c11836c5-6786-40b5-a4cc-a935a1cc2ed1/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 7 月 SHSE:605016 的债务股本比</p>
<h2>大连华锐重工集团（SZSE:002204）</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> 大连华锐重工集团有限公司在特种设备制造领域运营，市值约为 115.7 亿人民币。</p>
<p><strong>运营：</strong> 该公司从其特种设备制造部门产生了 146 亿人民币的收入。</p>
<p>大连华锐重工集团在过去一年显示出 36.6% 的可观盈利增长，超越了机械行业的 1%。尽管其债务股本比在五年内从 7.6% 上升至 22.3%，但它持有的现金超过总债务，确保了财务稳定。公司的市盈率为 23.8 倍，相较于中国市场的 39.6 倍，暗示潜在的低估。最近的发展包括 2024 年每股派息 0.50 元的增加，以及在今年 4 月的股东大会上批准的章程修订。</p>
<ul>
<li>在这里深入了解大连华锐重工集团的完整分析健康报告。</li>
<li>通过我们的详细历史业绩报告评估大连华锐重工集团的过去表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2d9ed701-39b6-4e8d-b30c-466188b1a02a/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2d9ed701-39b6-4e8d-b30c-466188b1a02a/chart/earnings-and-revenue-growth"/></p>
<p>截至 2025 年 7 月 SZSE:002204 的盈利和收入增长</p>
<h2>北京 SDL 科技有限公司（SZSE:002658）</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 北京 SDL 科技有限公司及其子公司开发和销售环境监测设备和解决方案，市场价值为 53.8 亿人民币。</p>
<p><strong>运营：</strong> 该公司的收入主要来自环境监测设备和解决方案的销售。其财务表现以净利润率为亮点，反映出其相对于收入有效管理成本的能力。</p>
<p>北京 SDL 科技在过去一年显示出 10% 的显著盈利增长，超越了电子行业的 2.9%。该公司的债务股本比在五年内显著下降，从 21.5% 降至仅 0.07%，展示出强大的财务纪律。其市盈率为 32 倍，相较于中国市场的平均水平 39.6 倍，具有吸引力。最近的报告显示盈利能力的扭转，净收入达到 1000 万人民币，而去年则出现亏损，销售额从 2.31 亿人民币攀升至 2.54 亿人民币，成为今年第一季度的亮点。</p>
<ul>
<li>在这份健康报告中解锁我们对北京 SDL 科技有限公司股票分析的全面见解。</li>
<li>通过检查我们的历史报告了解北京 SDL 科技有限公司的业绩记录。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8ae9fbfc-676f-4990-99e4-6f8ba838416e/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8ae9fbfc-676f-4990-99e4-6f8ba838416e/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 7 月 SZSE:002658 的债务股本比</p>
<h2>让它发生</h2>
<ul>
<li>在这里深入了解我们完整的 3161 个全球未被发现的基本面强劲的投资机会。</li>
<li>已经拥有这些公司的股票？将您的投资组合链接到 Simply Wall St，并获取有关您股票的新警示信息。</li>
<li>免费使用 Simply Wall St 的应用程序简化您的投资策略，并受益于对全球各地股票的广泛研究。</li>
</ul>
<h2>准备好尝试不同的方法了吗？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成购买或出售任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

百龙创园

<p>随着全球市场的反弹，小型股在温和的通胀和混合的经济指标中表现出色。山东百龙创园生物科技显示出 35.3% 的可观盈利增长，并且其交易价格低于估算的公允价值，表明可能被低估。大连华瑞重工集团也展现出 36.6% 的强劲盈利增长和良好的市盈率。同时，北京 SDL 科技实现了盈利能力的显著扭转，净收入达到 1000 万元人民币。这些公司被认为是具有强大基本面的有前景的小型股投资</p>

<p>As global markets experience a rally with key indices like the S&amp;P 500 and Nasdaq Composite reaching all-time highs, small-cap stocks are navigating a complex landscape marked by modest inflation upticks and mixed economic indicators. In this dynamic environment, identifying promising small-cap companies involves looking for those with strong fundamentals and potential growth drivers that can withstand broader market fluctuations.</p>
<div class="lb-trans"><p>随着全球市场经历反弹，标普 500 指数和纳斯达克综合指数创下历史新高，小型股在温和通胀上升和经济指标混杂的复杂环境中航行。在这种动态环境中，识别有前景的小型公司需要关注那些具有强大基本面和潜在增长驱动因素的公司，以抵御更广泛市场的波动。</p>
</div><h3>Top 10 Undiscovered Gems With Strong Fundamentals Globally</h3>
<div class="lb-trans"><h3>全球十大未被发现的基本面强劲的宝藏股</h3>
</div><table>
<thead>
<tr>
<th>Name</th>
<th>Debt To Equity</th>
<th>Revenue Growth</th>
<th>Earnings Growth</th>
<th>Health Rating</th>
</tr>
</thead>
<tbody>
<tr>
<td>AIC</td>
<td>NA</td>
<td>26.88%</td>
<td>54.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>CTCI Advanced Systems</td>
<td>39.96%</td>
<td>21.96%</td>
<td>24.04%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Advanced International Multitech</td>
<td>35.32%</td>
<td>3.62%</td>
<td>1.11%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Saha-Union</td>
<td>0.84%</td>
<td>0.90%</td>
<td>15.45%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Alf Meem Yaa for Medical Supplies and Equipment</td>
<td>NA</td>
<td>17.03%</td>
<td>18.37%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Nofoth Food Products</td>
<td>NA</td>
<td>15.75%</td>
<td>27.63%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Hong Leong Finance</td>
<td>0.07%</td>
<td>6.89%</td>
<td>6.61%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Sing Investments &amp; Finance</td>
<td>0.29%</td>
<td>9.07%</td>
<td>12.24%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Mechema Chemicals International</td>
<td>55.74%</td>
<td>-4.23%</td>
<td>-5.72%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>National Corporation for Tourism and Hotels</td>
<td>19.25%</td>
<td>0.67%</td>
<td>4.89%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>名称</th>
<th>债务股本比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>AIC</td>
<td>不适用</td>
<td>26.88%</td>
<td>54.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>CTCI 先进系统</td>
<td>39.96%</td>
<td>21.96%</td>
<td>24.04%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>先进国际多技术</td>
<td>35.32%</td>
<td>3.62%</td>
<td>1.11%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Saha-Union</td>
<td>0.84%</td>
<td>0.90%</td>
<td>15.45%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Alf Meem Yaa 医疗器械和设备</td>
<td>不适用</td>
<td>17.03%</td>
<td>18.37%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Nofoth 食品产品</td>
<td>不适用</td>
<td>15.75%</td>
<td>27.63%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>洪亮金融</td>
<td>0.07%</td>
<td>6.89%</td>
<td>6.61%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>新加坡投资与金融</td>
<td>0.29%</td>
<td>9.07%</td>
<td>12.24%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Mechema 化学国际</td>
<td>55.74%</td>
<td>-4.23%</td>
<td>-5.72%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>国家旅游与酒店公司</td>
<td>19.25%</td>
<td>0.67%</td>
<td>4.89%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 3161 stocks from our Global Undiscovered Gems With Strong Fundamentals screener.</p>
<div class="lb-trans"><p>点击这里查看我们全球未被发现的基本面强劲的宝藏股筛选器中的 3161 只股票的完整列表。</p>
</div><p>Below we spotlight a couple of our favorites from our exclusive screener.</p>
<div class="lb-trans"><p>在这里，我们重点介绍我们独家的筛选器中的几只最爱。</p>
</div><h2>Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016)</h2>
<div class="lb-trans"><h2>山东百龙创园生物科技（SHSE:605016）</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. operates in the biotechnology sector and has a market capitalization of CN¥8.80 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 山东百龙创园生物科技有限公司在生物技术领域运营，市值为 88 亿人民币。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from its biotechnology operations. It has a market capitalization of approximately CN¥8.80 billion, indicating its significant presence in the sector.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过其生物技术业务产生收入。其市值约为 88 亿人民币，显示出其在该领域的重要地位。</p>
</div><p>Shandong Bailong Chuangyuan Bio-Tech, a nimble player in the bio-tech sector, has shown impressive earnings growth of 35.3% over the past year, outpacing its industry peers who faced a downturn. The company trades at 7.1% below its estimated fair value, suggesting potential undervaluation. With more cash than total debt and a reduced debt-to-equity ratio from 9% to 8.5% over five years, financial health seems robust. Recent quarterly results highlight strong performance with sales climbing to CNY 313 million from CNY 252 million and net income rising to CNY 81 million from CNY 54 million year-on-year.</p>
<div class="lb-trans"><p>山东百龙创园生物科技作为生物技术领域的灵活参与者，过去一年显示出 35.3% 的可观盈利增长，超越了面临下滑的行业同行。该公司的交易价格低于其估计的公允价值 7.1%，暗示潜在的低估。公司现金多于总债务，且债务股本比在五年内从 9% 降至 8.5%，财务健康状况似乎稳健。最近的季度业绩显示强劲表现，销售额从 2.52 亿人民币攀升至 3.13 亿人民币，净收入从 5400 万人民币上升至 8100 万人民币，同比增加。</p>
</div><ul>
<li>Take a closer look at Shandong Bailong Chuangyuan Bio-Tech's potential here in our health report.</li>
<li>Gain insights into Shandong Bailong Chuangyuan Bio-Tech's past trends and performance with our Past report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的健康报告中更详细地了解山东百龙创园生物科技的潜力。</li>
<li>通过我们的历史报告深入了解山东百龙创园生物科技的过去趋势和表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/c11836c5-6786-40b5-a4cc-a935a1cc2ed1/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/c11836c5-6786-40b5-a4cc-a935a1cc2ed1/chart/debt-equity-history-analysis"/></p>
<p>SHSE:605016 Debt to Equity as at Jul 2025</p>
<div class="lb-trans"><p>截至 2025 年 7 月 SHSE:605016 的债务股本比</p>
</div><h2>Dalian Huarui Heavy Industry Group (SZSE:002204)</h2>
<div class="lb-trans"><h2>大连华锐重工集团（SZSE:002204）</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Dalian Huarui Heavy Industry Group Co., Ltd. operates in the special-purpose equipment manufacturing sector and has a market capitalization of approximately CN¥11.57 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 大连华锐重工集团有限公司在特种设备制造领域运营，市值约为 115.7 亿人民币。</p>
</div><p><strong>Operations:</strong> The company generated revenue of CN¥14.60 billion from its special-purpose equipment manufacturing segment.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司从其特种设备制造部门产生了 146 亿人民币的收入。</p>
</div><p>Dalian Huarui Heavy Industry Group has shown impressive earnings growth of 36.6% over the past year, outpacing the Machinery industry's 1%. Despite a rise in its debt to equity ratio from 7.6% to 22.3% over five years, it holds more cash than total debt, ensuring financial stability. The company's price-to-earnings ratio stands at a favorable 23.8x compared to the CN market's 39.6x, suggesting potential undervaluation. Recent developments include a dividend increase with CNY 0.50 per share for 2024 and amendments to its articles of association approved during their AGM in April this year.</p>
<div class="lb-trans"><p>大连华锐重工集团在过去一年显示出 36.6% 的可观盈利增长，超越了机械行业的 1%。尽管其债务股本比在五年内从 7.6% 上升至 22.3%，但它持有的现金超过总债务，确保了财务稳定。公司的市盈率为 23.8 倍，相较于中国市场的 39.6 倍，暗示潜在的低估。最近的发展包括 2024 年每股派息 0.50 元的增加，以及在今年 4 月的股东大会上批准的章程修订。</p>
</div><ul>
<li>Delve into the full analysis health report here for a deeper understanding of Dalian Huarui Heavy Industry Group.</li>
<li>Assess Dalian Huarui Heavy Industry Group's past performance with our detailed historical performance reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里深入了解大连华锐重工集团的完整分析健康报告。</li>
<li>通过我们的详细历史业绩报告评估大连华锐重工集团的过去表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2d9ed701-39b6-4e8d-b30c-466188b1a02a/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/2d9ed701-39b6-4e8d-b30c-466188b1a02a/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:002204 Earnings and Revenue Growth as at Jul 2025</p>
<div class="lb-trans"><p>截至 2025 年 7 月 SZSE:002204 的盈利和收入增长</p>
</div><h2>Beijing SDL TechnologyLtd (SZSE:002658)</h2>
<div class="lb-trans"><h2>北京 SDL 科技有限公司（SZSE:002658）</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Beijing SDL Technology Co., Ltd. and its subsidiaries develop and sell environmental monitoring equipment and solutions both in China and internationally, with a market cap of CN¥5.38 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 北京 SDL 科技有限公司及其子公司开发和销售环境监测设备和解决方案，市场价值为 53.8 亿人民币。</p>
</div><p><strong>Operations:</strong> The company's revenue primarily comes from the sale of environmental monitoring equipment and solutions. Its financial performance is highlighted by a net profit margin that reflects its ability to manage costs effectively relative to its revenue.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司的收入主要来自环境监测设备和解决方案的销售。其财务表现以净利润率为亮点，反映出其相对于收入有效管理成本的能力。</p>
</div><p>Beijing SDL Technology has been making waves with a notable earnings growth of 10% over the past year, outpacing the electronic industry's 2.9%. The company's debt to equity ratio impressively dropped from 21.5% to just 0.07% in five years, showcasing strong financial discipline. Its price-to-earnings ratio stands at 32x, which is attractive compared to the CN market's average of 39.6x. Recent reports highlight a turnaround in profitability, with net income reaching CNY 10 million versus a loss last year and sales climbing from CNY 231 million to CNY 254 million for Q1 of this year.</p>
<div class="lb-trans"><p>北京 SDL 科技在过去一年显示出 10% 的显著盈利增长，超越了电子行业的 2.9%。该公司的债务股本比在五年内显著下降，从 21.5% 降至仅 0.07%，展示出强大的财务纪律。其市盈率为 32 倍，相较于中国市场的平均水平 39.6 倍，具有吸引力。最近的报告显示盈利能力的扭转，净收入达到 1000 万人民币，而去年则出现亏损，销售额从 2.31 亿人民币攀升至 2.54 亿人民币，成为今年第一季度的亮点。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Beijing SDL TechnologyLtd stock in this health report.</li>
<li>Understand Beijing SDL TechnologyLtd's track record by examining our Past report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这份健康报告中解锁我们对北京 SDL 科技有限公司股票分析的全面见解。</li>
<li>通过检查我们的历史报告了解北京 SDL 科技有限公司的业绩记录。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8ae9fbfc-676f-4990-99e4-6f8ba838416e/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/8ae9fbfc-676f-4990-99e4-6f8ba838416e/chart/debt-equity-history-analysis"/></p>
<p>SZSE:002658 Debt to Equity as at Jul 2025</p>
<div class="lb-trans"><p>截至 2025 年 7 月 SZSE:002658 的债务股本比</p>
</div><h2>Make It Happen</h2>
<div class="lb-trans"><h2>让它发生</h2>
</div><ul>
<li>Delve into our full catalog of 3161 Global Undiscovered Gems With Strong Fundamentals here.</li>
<li>Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.</li>
<li>Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里深入了解我们完整的 3161 个全球未被发现的基本面强劲的投资机会。</li>
<li>已经拥有这些公司的股票？将您的投资组合链接到 Simply Wall St，并获取有关您股票的新警示信息。</li>
<li>免费使用 Simply Wall St 的应用程序简化您的投资策略，并受益于对全球各地股票的广泛研究。</li>
</ul>
</div><h2>Ready For A Different Approach?</h2>
<div class="lb-trans"><h2>准备好尝试不同的方法了吗？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
<li>Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成购买或出售任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

探索山东百龙创园生物科技及全球市场中两个有前景的小盘股